These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37033235)

  • 1. Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study.
    Jackova Z; Stepan JJ; Coufal S; Kostovcik M; Galanova N; Reiss Z; Pavelka K; Wenchich L; Hruskova H; Kverka M
    Front Endocrinol (Lausanne); 2023; 14():1139056. PubMed ID: 37033235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women.
    Gourlay ML; Preisser JS; Hammett-Stabler CA; Renner JB; Rubin J
    Osteoporos Int; 2011 Oct; 22(10):2699-708. PubMed ID: 21125395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism.
    Baloun J; Pekacova A; Wenchich L; Hruskova H; Senolt L; Svec X; Pavelka K; Stepan JJ
    Front Endocrinol (Lausanne); 2022; 13():864299. PubMed ID: 35634507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
    Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women.
    Ozaki D; Kubota R; Maeno T; Abdelhakim M; Hitosugi N
    Osteoporos Int; 2021 Jan; 32(1):145-156. PubMed ID: 33241467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation.
    Kotsopoulos J; Hall E; Finch A; Hu H; Murphy J; Rosen B; Narod SA; Cheung AM
    JAMA Netw Open; 2019 Aug; 2(8):e198420. PubMed ID: 31390031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An emerging role of Prevotella histicola on estrogen deficiency-induced bone loss through the gut microbiota-bone axis in postmenopausal women and in ovariectomized mice.
    Wang Z; Chen K; Wu C; Chen J; Pan H; Liu Y; Wu P; Yuan J; Huang F; Lang J; Du J; Xu J; Jin K; Chen L
    Am J Clin Nutr; 2021 Oct; 114(4):1304-1313. PubMed ID: 34113963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN; Hammami MM; Bakheet SM; Khan BA
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China.
    Li C; Huang Q; Yang R; Dai Y; Zeng Y; Tao L; Li X; Zeng J; Wang Q
    Osteoporos Int; 2019 May; 30(5):1003-1013. PubMed ID: 30666372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study).
    Jiang H; Robinson DL; Lee PVS; Krejany EO; Yates CJ; Hickey M; Wark JD
    Osteoporos Int; 2021 Jan; 32(1):101-112. PubMed ID: 32856124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The associations of gut microbiota and fecal short-chain fatty acids with bone mass were largely mediated by weight status: a cross-sectional study.
    Chen F; Wei Q; Xu D; Wei Y; Wang J; Amakye WK; Pan J; Cui Z; Zhang Z
    Eur J Nutr; 2021 Dec; 60(8):4505-4517. PubMed ID: 34129072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and fractures in Turner syndrome.
    Bakalov VK; Chen ML; Baron J; Hanton LB; Reynolds JC; Stratakis CA; Axelrod LE; Bondy CA
    Am J Med; 2003 Sep; 115(4):259-64. PubMed ID: 12967689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevention of bone mineral loss with hormonal replacement therapy in premenopausal women on dialysis with estrogen deficiency].
    Matuszkiewicz-Rowińska J; Skórzewska K; Radowicki S; Sokalski A; Niemczyk S; Wardyn K; Włodarczyk D; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 1999 Aug; 102(2):665-70. PubMed ID: 10948698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone.
    Mueller A; Dittrich R; Binder H; Kuehnel W; Maltaris T; Hoffmann I; Beckmann MW
    Eur J Endocrinol; 2005 Jul; 153(1):107-13. PubMed ID: 15994752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
    Jing Y; Wang X; Yu J; Wang X; Zhou Y; Tao B; Sun L; Liu J; Zhao H
    J Diabetes; 2020 Jun; 12(6):426-437. PubMed ID: 31778286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study.
    Van Caenegem E; Wierckx K; Taes Y; Schreiner T; Vandewalle S; Toye K; Kaufman JM; T'Sjoen G
    Osteoporos Int; 2015 Jan; 26(1):35-47. PubMed ID: 25377496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.